Serrapeptase References

Updated: March 17, 2017

([lastupdate format=”F j, Y”])

  • Academy of Breastfeeding Medicine Protocol Committee, Berens P. ABM clinical protocol #20: Engorgement. Breastfeed Med. 2009 Jun;4(2):111-3. PubMed PMID: 19517578.
  • Al-Khateeb TH, Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. Int J Oral Maxillofac Surg. 2008 Mar;37(3) 264-268. doi:10.1016/j.ijom.2007.11.011. PMID: 18272344.
  • Al-Khateeb TH, Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. Int J Oral Maxillofac Surg. 2008 Mar;37(3):264-8. doi: 10.1016/j.ijom.2007.11.011. Epub 2008 Feb 12. PubMed PMID: 18272344.
  • Al-Khateeb, T.H. and Nusair, Y. “Effect of the Proteolytic Enzyme Serrapeptase on Swelling, Pain and Trismus After Surgical Extraction of Mandibular Third Molars.” International Journal of Oral and Maxillofacial Surgery, March 2008, Vol. 37, No. 3, pp. 264-8.
  • Alessandrini A, Ferrari D, Bastianon A, Maccagno A. [Granulated feprazone in acute inflammatory pathology of the bronchial tree. Study in comparison to a serratiopeptidase]. Clin Ter. 1985 May 31;113(4):275-80. Italian. PubMed PMID: 3893867.
  • Alherbish A, Charrois TL, Ackman ML, Tsuyuki RT, Ezekowitz JA. The prevalence of natural health product use in patients with acute cardiovascular disease. PLoS One. 2011;6(5) e19623. doi:10.1371/journal.pone.0019623. PMID: 21573067; PMCID: PMC3090400.
  • Aratani H, Kono S, Yamanaka Y. [Fundamental studies on the distribution of sulfobenzylpenicillin. Effect of serratiopeptidase (author’s transl)]. Jpn J Antibiot. 1974 Jun;27(3):271-8. Japanese. PubMed PMID: 4436946.
  • Aratani H, Tateishi H, Negita S. [Studies on in vivo activity of antibiotics in experimental pneumonia in rats. I. Combination of ciclacillin and serratiopeptidase (author’s transl)]. Jpn J Antibiot. 1979 Aug;32(8):806-11. Japanese. PubMed PMID: 490898.
  • Aratani H, Tateishi H, Negita S. [Studies on the distributions of antibiotics in the oral tissues: Experimental staphylococcal infection in rats, and effect of serratiopeptidase on the distributions of antibiotics (author’s transl)]. Jpn J Antibiot. 1980 May;33(5):623-35. Japanese. PubMed PMID: 7001087.
  • Artini M, Papa R, Scoarughi GL, Galano E, Barbato G, Pucci P, Selan L. Comparison of the action of different proteases on virulence properties related to the staphylococcal surface. J Appl Microbiol. 2013 Jan;114(1):266-77. doi: 10.1111/jam.12038. Epub 2012 Nov 19. PubMed PMID: 23057709.
  • Artini M, Scoarughi GL, Papa R, Cellini A, Carpentieri A, Pucci P, Amoresano A, Gazzola S, Cocconcelli PS, Selan L. A new anti-infective strategy to reduce adhesion-mediated virulence in Staphylococcus aureus affecting surface proteins. Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):661-72. PubMed PMID: 21978698.
  • Aso T. et al. Breast engorgement and its treatment: Clinical effects of (Serrapeptase) an anti-inflammatory enzyme preparation. The world of Obstetrics and Gynaecology (Japanese). 1981:33:371-9.
  • Badhe RV, Nanda RK, Kulkarni MB, Bhujbal MN, Patil PS, Badhe SR. Media optimization studies for Serratiopeptidase production from Serratia marcescens ATCC 13880. Hindustan Antibiot Bull. 2009;51(1-4):17-23. PubMed PMID: 21268555.
  • Balaji SM. Use of recombinant human Bone Morphogenetic Protein (rhBMP-2) in reconstruction of maxillary alveolar clefts. J Maxillofac Oral Surg. 2009 Sep;8(3):211-7. doi: 10.1007/s12663-009-0052-5. Epub 2009 Nov 21. PubMed PMID: 23139510; PubMed Central PMCID: PMC3454232.
  • Balliett M, Burke JR. Changes in anthropometric measurements, body composition, blood pressure, lipid profile, and testosterone in patients participating in a low-energy dietary intervention. J Chiropr Med. 2013 Mar;12(1) 3-14. doi:10.1016/j.jcm.2012.11.003. PMID: 23997718; PMCID: PMC3610945.
  • Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. Int J Surg. 2013;11(3):209-17. doi: 10.1016/j.ijsu.2013.01.010. Epub 2013 Feb 1. Review. PubMed PMID: 23380245.
  • Bracale G, Selvetella L. [Clinical study of the efficacy of and tolerance to seaprose S in inflammatory venous disease. Controlled study versus serratio-peptidase]. Minerva Cardioangiol. 1996 Oct;44(10):515-24. Italian. PubMed PMID: 9091835.
  • Braga, P.C. et al. Effects of Serrapeptase on muco-ciliary clearance in patients with chronic bronchitis. Curr. Ther. Res. 29(5): 738-744,1981.
  • Bruno E, Porcellini A, Farronato GP. [Clinical study of a new oral anti-inflammatory: Zami 642]. Dent Cadmos. 1986 Oct 15;54(15):81-3. Italian. PubMed PMID: 3552763.
  • Bucci E, Mignogna MD, Bucci P. [Aulin: a new modern drug in the treatment of inflammation in dentistry]. Minerva Stomatol. 1987 Jan-Feb;36(1-2):101-3. Italian. PubMed PMID: 3553887.
  • Bucci E, Signoriello G, Perrino IF, Bucci P. [Clinico-pharmacological comparison between between enzyme-type anti-inflammatory agents postoperatively in oral surgery]. Minerva Stomatol. 1986 May;35(5):503-6. Italian. PubMed PMID: 3526117.
  • Caroppo E, Niederberger C, Iacovazzi PA, Correale M, D’Amato G. Detection of 90K/MAC-2BP in the seminal plasma of infertile males with accessory gland infection and the autoimmune pathogenetic hypothesis. J Androl. 2006 Nov-Dec;27(6):780-4. Epub 2006 Jul 12. PubMed PMID: 16837737.
  • Carratu, L. et al. Physio-chemical and rheological research on mucolytic activity of Serrapeptase in chronic broncho-pneumopathies. Curr. Ther. Res. 28(6): 937-951. 1980.
  • Chappi D M, Suresh KV, Patil MR, Desai R, Tauro DP, Bharani K N S S, Parkar MI, Babaji HV. Comparison of clinical efficacy of methylprednisolone and serratiopeptidase for reduction of postoperative sequelae after lower third molar surgery. J Clin Exp Dent. 2015 Apr 1;7(2):e197-202. doi: 10.4317/jced.51868. eCollection 2015 Apr. PubMed PMID: 26155332; PubMed Central PMCID: PMC4483323.
  • Chopra D, Rehan HS, Mehra P, Kakkar AK. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. Int J Oral Maxillofac Surg. 2009 Apr;38(4):350-5. doi: 10.1016/j.ijom.2008.12.013. Epub 2009 Jan 24. PubMed PMID: 19168326.
  • Dallas P, Rekkas D, Choulis NH. HPLC determination of serratiopeptidase in biological fluids. Pharmazie. 1989 Apr;44(4):297. PubMed PMID: 2672036.
  • Esch PM, Gemgross H. Fabian A. Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joints in treatment with Serrapeptase a prospective study (German). FortschrMed. 1989; 107(4): 67-8, 71-2.
  • Esch PM, Gerngross H, Fabian A. [Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase– a prospective study] Fortschr Med. 1989 Feb;107(4) 67-8, 71-2. PMID: 2647603.
  • Esch PM, Gerngross H, Fabian A. [Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase– a prospective study]. Fortschr Med. 1989 Feb 10;107(4):67-8, 71-2. German. PubMed PMID: 2647603.
  • Fadl NN, Ahmed HH, Booles HF, Sayed AH. Serrapeptase and nattokinase intervention for relieving Alzheimer’s disease pathophysiology in rat model. Hum Exp Toxicol. 2013 Jul;32(7) 721-735. doi:10.1177/0960327112467040. PMID: 23821590.
  • Fadl NN, Ahmed HH, Booles HF, Sayed AH. Serrapeptase and nattokinase intervention for relieving Alzheimer’s disease pathophysiology in rat model. Hum Exp Toxicol. 2013 Jul;32(7):721-35. doi: 10.1177/0960327112467040. PubMed PMID: 23821590.
  • Fujitani, T. et al. Effect of anti-inflammatory agent on transfer of antibiotics to the maxillary sinus mucosa in chronic sinusitis. Otorhinolaryngol. Clin. North Am. 66:557-565. 1976.
  • Furlong J, Rynders CA, Sutherlin M, Patrie J, Katch FI, Hertel J, Weltman A. Effect of an herbal/botanical supplement on strength, balance, and muscle function following 12-weeks of resistance training: a placebo controlled study. J Int Soc Sports Nutr. 2014;11 23. doi:10.1186/1550-2783-11-23. PMID: 24910543; PMCID: PMC4047772.
  • Harad, Y. Clinical efficacy of Serrapeptase on buccal swelling after radical operation for chronic sinusitis. Igaku Ayumi 123:768-778.1982.
  • Hirahara K, Saitoh T, Terada I, Uno K, Nagai A, Kioi S, Arakawa M. [A case of pneumonitis due to serrapeptase] Nihon Kyobu Shikkan Gakkai Zasshi. 1989 Oct;27(10) 1231-1236. PMID: 2693781.
  • Hirahara K, Saitoh T, Terada I, Uno K, Nagai A, Kioi S, Arakawa M. [A case of pneumonitis due to serrapeptase]. Nihon Kyobu Shikkan Gakkai Zasshi. 1989 Oct;27(10):1231-6. Japanese. PubMed PMID: 2693781.
  • Ijitsu T, Yonezawa K, Ueno M. [Improved analysis of serrapeptase by high performance steric exclusion chromatography (SEC). I] Yakugaku Zasshi. 1986 Jan;106(1) 95-98. PMID: 3517293.
  • Ijitsu T, Yonezawa K, Ueno M. [Improved analysis of serrapeptase by high performance steric exclusion chromatography (SEC). I]. Yakugaku Zasshi. 1986 Jan;106(1):95-8. Japanese. PubMed PMID: 3517293.
  • Ishihara Y, Kitamura S, Takaku F. [Experimental studies on distribution of cefotiam, a new beta-lactam antibiotic, in the lung and trachea of rabbits. II. Combined effects with serratiopeptidase]. Jpn J Antibiot. 1983 Oct;36(10):2665-70. Japanese. PubMed PMID: 6325734.
  • Jadav SP, Patel NH, Shah TG, Gajera MV, Trivedi HR, Shah BK. Comparison of anti-inflammatory activity of serratiopeptidase and diclofenac in albino rats. J Pharmacol Pharmacother. 2010 Jul;1(2):116-7. doi: 10.4103/0976-500X.72362. PubMed PMID: 21350623; PubMed Central PMCID: PMC3043339.
  • Jadav, S.P., et. al. “Comparison of Anti-Inflammatory Activity of Serratiopeptidase and Diclofenac in Albino Rats.” Journal of Pharmacology and Pharmacotherapeutics, 2010, Vol. 1, No. 2, pp. 116-17.
  • Joshi KK, Nerurkar RP. Anti-inflammatory effect of the serratiopeptidase–rationale or fashionable: a study in rat paw oedema model induced by the carrageenan. Indian J Physiol Pharmacol. 2012 Oct-Dec;56(4):367-74. PubMed PMID: 23781657.
  • Kai N, Shirai R, Hirata N, Iwata A, Umeki K, Ishii H, Kishi K, Tokimatsu I, Hiramatsu K, Kadota J. [A case of eosinophilic pneumonia due to Nicolase (serrapeptase) after recovery from acute eosinophilic pneumonia]. Nihon Kokyuki Gakkai Zasshi. 2009 Mar;47(3) 254-258. PMID: 19348276.
  • Kai N, Shirai R, Hirata N, Iwata A, Umeki K, Ishii H, Kishi K, Tokimatsu I, Hiramatsu K, Kadota J. [A case of eosinophilic pneumonia due to Nicolase (serrapeptase) after recovery from acute eosinophilic pneumonia]. Nihon Kokyuki Gakkai Zasshi. 2009 Mar;47(3):254-8. Japanese. PubMed PMID: 19348276.
  • Kakinumu, A. et al. Regression of fibrinolysis in scalded rats by administration of Serrapeptase. Biochem. Pharmacol. 31:2861-2866,1982.
  • Kasé Y, Seo H, Oyama Y, Sakata M, Tomoda K, Takahama K, Hitoshi T, Okano Y, Miyata T. A new method for evaluating mucolytic expectorant activity and its application. II. Application to two proteolytic enzymes, serratiopeptidase and seaprose. Arzneimittelforschung. 1982;32(4):374-8. PubMed PMID: 7049188.
  • Kase, Y. et al. A new method for evaluating mucolytic expectorant activity and its application. II. Application to two proteolytic enzymes, Serrapeptase and seaprose. Arzneimittelforschung 32:374-378,1982.
  • Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial. Singapore Med J. 1989 Feb;30(1) 48-54. PMID: 2688125.
  • Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial. Singapore Med J. 1989 Feb;30(1):48-54. PubMed PMID: 2688125.
  • Kee WH. Tan SL, Lee V. Salmon YM. The treatment of breast engorgement with Serrapeptase: a randomised double blind controlled trial. Singapore Med J. 1989:30(1): 48-54.
  • Koga Y, Mishima Y, Saho M, Ito A, Ito T, Hiraki T, Ushijima K. A case of serious laryngeal edema unpredictably detected during laryngoscopy for orotracheal intubation following induction of anesthesia. J Anesth. 2011 Aug;25(4) 589-591. doi:10.1007/s00540-011-1150-3. PMID: 21533587; PMCID: PMC3152709.
  • Kotb E. The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi. Biotechnol Prog. 2014 May-Jun;30(3) 656-672. doi:10.1002/btpr.1918. PMID: 24799449.
  • Kotb E. The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi. Biotechnol Prog. 2014 May-Jun;30(3):656-72. doi: 10.1002/btpr.1918. Epub 2014 May 7. Review. PubMed PMID: 24799449.
  • Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, Murakami K, Komatsu H, Hirata M, Arai T, et al. Augmentation by Serrapeptase of tissue permeation by cefotiam (Japanese). Jpn JAntibiot. 1986; 39(3): 761-71.
  • Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, Murakami K, Komatsu H, Hirata M, Arai T. [Augmentation by serrapeptase of tissue permeation by cefotiam] Jpn J Antibiot. 1986 Mar;39(3) 761-771. PMID: 3525882.
  • Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, Murakami K, Komatsu H, Hirata M, Arai T, et al. [Augmentation by serrapeptase of tissue permeation by cefotiam]. Jpn J Antibiot. 1986 Mar;39(3):761-71. Japanese. PubMed PMID: 3525882.
  • Kumar S, Jana AK, Dhamija I, Maiti M. Chitosan-assisted immobilization of serratiopeptidase on magnetic nanoparticles, characterization and its target delivery. J Drug Target. 2014 Feb;22(2):123-37. doi: 10.3109/1061186X.2013.844157. Epub 2013 Oct 23. PubMed PMID: 24148085.
  • Kumar S, Jana AK, Dhamija I, Singla Y, Maiti M. Preparation, characterization and targeted delivery of serratiopeptidase immobilized on amino-functionalized magnetic nanoparticles. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):413-26. doi: 10.1016/j.ejpb.2013.06.019. Epub 2013 Jul 10. PubMed PMID: 23851102.
  • Kumari N, Pathak K. Dual controlled release, in situ gelling periodontal sol of metronidazole benzoate and serratiopeptidase: statistical optimization and mechanistic evaluation. Curr Drug Deliv. 2012 Jan;9(1):74-84. PubMed PMID: 22023207.
  • KV S, Devi GS, Mathew ST. Liposomal formulations of serratiopeptidase: in vitro studies using PAMPA and Caco-2 models. Mol Pharm. 2008 Jan-Feb;5(1):92-7. Epub 2007 Dec 27. PubMed PMID: 18159928.
  • Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel H, Benhamou JP. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut. 1992 Mar;33(3) 368-371. doi:10.1136/gut.33.3.368. PMID: 1568657; PMCID: PMC1373830.
  • Lee HS, Majima Y, Sakakura Y, Kim BW. A technique for quantitative cytology of nasal secretions. Eur Arch Otorhinolaryngol. 1991;248(7):406-8. PubMed PMID: 1747249.
  • Longhi C, Scoarughi GL, Poggiali F, Cellini A, Carpentieri A, Seganti L, Pucci P, Amoresano A, Cocconcelli PS, Artini M, Costerton JW, Selan L. Protease treatment affects both invasion ability and biofilm formation in Listeria monocytogenes. Microb Pathog. 2008 Jul;45(1):45-52. doi: 10.1016/j.micpath.2008.01.007. Epub 2008 Mar 25. PubMed PMID: 18479885.
  • Longhi, C., et. al. “Protease Treatment Affects Both Invasion Ability and Biofilm Formation in Listeria Monocytogenes.” Microbial Pathogenesis, July 2008, Vol. 45, No. 1, pp. 45-52.
  • Maheshwari M, Miglani G, Mali A, Paradkar A, Yamamura S, Kadam S. Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study. AAPS PharmSciTech. 2006 Sep 15;7(3):76. PubMed PMID: 17025256; PubMed Central PMCID: PMC2750518.
  • Majima Y, Hirata K, Takeuchi K, Hattori M, Sakakura Y. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am Rev Respir Dis. 1990 Jan;141(1):79-83. PubMed PMID: 2404442.
  • Majima Y, Inagaki M, Hirata K, Takeuchi K, Morishita A, Sakakura Y. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus. Arch Otorhinolaryngol. 1988;244(6):355-9. PubMed PMID: 3279939.
  • Majima Y, lnagaki M, Hirata K. Takeuchi K, M orishita A, Sakakura Y. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus. Arch Otorhinolaryngol. 1988; 244(6):355-9.
  • Majima. Y. et al. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am. Rev. Respit. Dis. 141:79-83.1990.
  • Mali N, Wavikar P, Vavia P. Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: in vitro and in vivo evaluation. AAPS PharmSciTech. 2015 Feb;16(1):59-66. doi: 10.1208/s12249-014-0201-0. Epub 2014 Aug 30. PubMed PMID: 25171974; PubMed Central PMCID: PMC4309803.
  • Malshe PC. A preliminary trial of serratiopeptidase in patients with carpal tunnel Syndrome. J Assoc Physicians India. 2000 Nov;48(11):1130. PubMed PMID: 11310402.
  • Malshe PC. Orally administered serratiopeptidase: can it work? J Assoc Physicians India. 1998 May;46(5):492. PubMed PMID: 11273304.
  • Mangesi L, Dowswell T. Treatments for breast engorgement during lactation. Cochrane Database Syst Rev. 2010 CD006946. doi:10.1002/14651858.cd006946.pub2. PMID: 20824853; PMCID: PMC4161489.
  • Marly, M. Enzymotherapie anti-inflammatoire a l’aide de la Serrapeptase: resultats cliniques en traumatologie et en ORL. C RTherapeut. 3:9-19,1985.
  • Marriott, C. Modification of the rheoloaical properties of mucus by drugs. Adv. Exp. Med. Biol. 144^75-84, 1982.
  • Matsudo, A. et at. Effect of Serrapeptase on inflammatory oedema following operation for thyropid disease. Med. Consult. New Remedy 18:171-175, 1981.
  • Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, Guarini E, Vesperini G. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res. 1990 Sep-Oct;18(5):379-88. PubMed PMID: 2257960.
  • Mazzonie, A. et al. Evaluation of Serrapeptase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double blind randomised trial versus placebo. J. Int. Med. Res. 18(5): 379-388,1990.
  • Mazzonie, A. et al. Evaluation of Serrapeptase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double blind randomised trial versus placebo. J. int. Med. Res. 18(5): 379-388,1990.
  • Mecikoglu M, Saygi B, Yildirim Y, Karadag-Saygi E, Ramadan SS, Esemenli T. The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection. J Bone Joint Surg Am. 2006 Jun;88(6):1208-14. PubMed PMID: 16757752.
  • Merten HA, Müller K, Drubel F, Halling F. [Volumetric verification of edema protection with Serrapeptase after third molar osteotomy] Dtsch Z Mund Kiefer Gesichtschir. 1991 Jul-Aug;15(4) 302-305. PMID: 1816962.
  • Merten HA, Müller K, Drubel F, Halling F. [Volumetric verification of edema protection with Serrapeptase after third molar osteotomy]. Dtsch Z Mund Kiefer Gesichtschir. 1991 Jul-Aug;15(4):302-5. German. PubMed PMID: 1816962.
  • Miyata, K. Intestinal absorption of Serrapeptase. J ApplBiochem. 1980:2:111-16.
  • Mizukoshi, D. et al. A double blind clinical study of Serrapeptase in the treatment of chronic sinusitis. Igaku Ayrni 109:50-62.1979.
  • Modabber A, Rana M, Ghassemi A, Gerressen M, Gellrich NC, Hölzle F, Rana M. Three-dimensional evaluation of postoperative swelling in treatment of zygomatic bone fractures using two different cooling therapy methods: a randomized, observer-blind, prospective study. Trials. 2013;14 238. doi:10.1186/1745-6215-14-238. PMID: 23895539; PMCID: PMC3729713.
  • Moitra S, Sen S, Banerjee I, Das P, Tripathi SK. Diclofenac-serratiopeptidase combination induced stevens – johnson syndrome – a rare case report with review of literature. J Clin Diagn Res. 2014 Jul;8(7):YD08-11. doi: 10.7860/JCDR/2014/9509.4610. Epub 2014 Jul 20. PubMed PMID: 25177625; PubMed Central PMCID: PMC4149131.
  • Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, Kakinuma A. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem. 1994 Aug;20 ( Pt 1) 101-108. PMID: 7917060.
  • Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, Kakinuma A. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem. 1994 Aug;20 ( Pt 1):101-8. PubMed PMID: 7917060.
  • Murugesan K, Sreekumar K, Sabapathy B. Comparison of the roles of serratiopeptidase and dexamethasone in the control of inflammation and trismus following impacted third molar surgery. Indian J Dent Res. 2012 Nov-Dec;23(6):709-13. doi: 10.4103/0970-9290.111243. PubMed PMID: 23649050.
  • Nakamura S, Hashimoto Y, Mikami M, Yamanaka E, Soma T, Hino M, Azuma A, Kudoh S. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology. 2003 Sep;8(3) 316-320. doi:10.1046/j.1440-1843.2003.00482.x. PMID: 12911824.
  • Nakamura S, Hashimoto Y, Mikami M, Yamanaka E, Soma T, Hino M, Azuma A, Kudoh S. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology. 2003 Sep;8(3):316-20. PubMed PMID: 12911824.
  • Nakamura, S., et. al. “Effect of the Proteolytic Enzyme Serrapeptase in Patients with Chronic Airway Disease.” Respirology, September 2003, Vol. 8, No. 3, pp. 316-20.
  • National Institute of Neurological Disorders and Stroke: “Study Ties Cerebral Palsy to Inflammation and Blood-Clotting Abnormalities”
  • Nirale NM, Menon MD. Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation. Indian J Pharm Sci. 2010 Jan;72(1):65-71. doi: 10.4103/0250-474X.62246. PubMed PMID: 20582192; PubMed Central PMCID: PMC2883229.
  • Odagiri, J. et al. Clinical applications of Serrapeptase in sinusitis. Med. Consult. New Remedy 6:201-209, 1979.
  • Okumura H, Watanabe R, Kotoura Y, Nakane Y, Tangiku O. [Effects of a proteolytic-enzyme preparation used concomitantly with an antibiotic in osteoarticular infections (author’s transl)]. Jpn J Antibiot. 1977 Mar;30(3):223-7. Japanese. PubMed PMID: 853579.
  • Ovartlarnporn B, Kulwichit W, Hiranniramol S. Medication-induced esophageal injury: report of 17 cases with endoscopic documentation. Am J Gastroenterol. 1991 Jun;86(6):748-50. PubMed PMID: 2038999.
  • Panagariya A, Sharma AK. A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome. J Assoc Physicians India. 1999 Dec;47(12):1170-2. PubMed PMID: 11225219.
  • Panagariya A., Sharma, A.K. “A Preliminary Trial of Serrapeptase in Patients with Carpal Tunnel Syndrome.” Journal of the Association of Physicians of India, December 1999, Vol. 47, No. 12, pp. 1170-2.
  • Pansuriya R, Singhal R. Effects of dissolved oxygen and agitation on production of serratiopeptidase by Serratia marcescens NRRL B-23112 in stirred tank bioreactor and its kinetic modeling. J Microbiol Biotechnol. 2011 Apr;21(4):430-7. PubMed PMID: 21532328.
  • Pansuriya RC, Singhal RS. Evolutionary operation (EVOP) to optimize whey independent serratiopeptidase production from Serratia marcescens NRRL B-23112. J Microbiol Biotechnol. 2010 May;20(5):950-7. PubMed PMID: 20519921.
  • Pant KK, Das V, Grawal SP, Singh A, Khattri S, Nath R, Nischal A, Dabholkar P. PARFLEX–a very useful drug for management of surgical pain. J Indian Med Assoc. 2008 Jun;106(6):409-11. PubMed PMID: 18839656.
  • Pant, K.K., et. al. “PARFLEX – A Very Useful Drug for Management of Surgical Pain.” Journal of the Indian Medical Association, June 2008, vol. 106, No. 6, pp. 409-11.
  • Papa R, Artini M, Cellini A, Tilotta M, Galano E, Pucci P, Amoresano A, Selan L. A new anti-infective strategy to reduce the spreading of antibiotic resistance by the action on adhesion-mediated virulence factors in Staphylococcus aureus. Microb Pathog. 2013 Oct;63:44-53. doi: 10.1016/j.micpath.2013.05.003. Epub 2013 Jun 26. PubMed PMID: 23811076.
  • Rath G, Johal ES, Goyal AK. Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing. Artif Cells Blood Substit Immobil Biotechnol. 2011 Feb;39(1):44-50. doi: 10.3109/10731199.2010.494580. Epub 2010 Jun 17. PubMed PMID: 20553201.
  • Rawat M, Saraf S, Saraf S. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS PharmSciTech. 2007;8(4) E116. doi:10.1208/pt0804116. PMID: 18181537; PMCID: PMC2750702.
  • Rawat M, Saraf S, Saraf S. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS PharmSciTech. 2007 Dec 28;8(4):E116. doi: 10.1208/pt0804116. PubMed PMID: 18181537; PubMed Central PMCID: PMC2750702.
  • Rawat M, Saraf S. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres. J Microencapsul. 2009 Jun;26(4):306-14. doi: 10.1080/02652040802319767. Epub 2008 Oct 20. PubMed PMID: 18686142.
  • Rawat M, Singh D, Saraf S, Saraf S. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm. 2008 Feb;34(2):181-8. doi: 10.1080/03639040701539479. PubMed PMID: 18302037.
  • Rynders CA, Weltman JY, Rynders SD, Patrie J, McKnight J, Katch FI, Hertel J, Weltman A. Effect of an herbal/botanical supplement on recovery from delayed onset muscle soreness: a randomized placebo-controlled trial. J Int Soc Sports Nutr. 2014;11 27. doi:10.1186/1550-2783-11-27. PMID: 24966805; PMCID: PMC4071077.
  • Salamone PR, Wodzinski RJ. Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl Microbiol Biotechnol. 1997 Sep;48(3):317-24. PubMed PMID: 9352674.
  • Salvato A, Zambruno E, Ventrini E, Savio G. [Clinical experiments with a new oral anti-edema drug: nimesulide]. G Stomatol Ortognatodonzia. 1984 Apr-Jun;3(2):184-91. Italian. PubMed PMID: 6396255.
  • Sandhya KV, Devi SG, Mathew ST. Quantitation of serrapeptase in formulations by UV method in the microplate format. Curr Drug Deliv. 2008 Oct;5(4) 303-305. PMID: 18855600.
  • Sandhya KV, Devi SG, Mathew ST. Quantitation of serrapeptase in formulations by UV method in the microplate format. Curr Drug Deliv. 2008 Oct;5(4):303-5. PubMed PMID: 18855600.
  • Sannino G, Gigola P, Puttini M, Pera F, Passariello C. Combination therapy including serratiopeptidase improves outcomes of mechanical-antibiotic treatment of periimplantitis. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):825-31. PubMed PMID: 24067485.
  • Sasaki S, Kawanami R, Motizuki Y, Nakahara Y, Kawamura T, Tanaka A, Watanabe S. [Serrapeptase-induced lung injury manifesting as acute eosiniphilic pneumonia]. Nihon Kokyuki Gakkai Zasshi. 2000 Jul;38(7) 540-544. PMID: 11019569.
  • Sasaki S, Kawanami R, Motizuki Y, Nakahara Y, Kawamura T, Tanaka A, Watanabe S. [Serrapeptase-induced lung injury manifesting as acute eosiniphilic pneumonia]. Nihon Kokyuki Gakkai Zasshi. 2000 Jul;38(7):540-4. Japanese. PubMed PMID: 11019569.
  • Scremin S, Gini M, Schiavi M, Ciani D, Caprioglio L. [Comparison between imidazole-2-hydroxybenzoate and serratio-peptidase in the treatment of phlogistic diseases of the respiratory tract]. Boll Chim Farm. 1985 Aug;124(8):71S-75S. Italian. PubMed PMID: 3911996.
  • Selan L, Berlutti F, Passariello C, Comodi-Ballanti MR, Thaller MC. Proteolytic enzymes: a new treatment strategy for prosthetic infections? Antimicrob Agents Chemother. 1993 Dec;37(12):2618-21. PubMed PMID: 8109925; PubMed Central PMCID: PMC192756.
  • Selan L, Berlutti F, Passariello C. Comodi-Ballanti MR, Thaller MC. Proteolytic enzymes: a new treatment strategy for prosthetic infections? Antimicrob Agents Cheroother. 1993; 37(12): 2618-21.
  • Serheieva IIe. [Pathogenetic substantiation of using peptidases in the treatment of patients with generalized periodontitis]. Fiziol Zh. 2013;59(2):85-91. Ukrainian. PubMed PMID: 23828974.
  • Shimizu H, Ueda M, Takai T, Bito T, Ichihashi M, Muramatsu T, Shirai T. A case of serratiopeptidase-induced subepidermal bullous dermatosis. Br J Dermatol. 1999 Dec;141(6):1139-40. PubMed PMID: 10722270.
  • Shimura S, Okubo T, Maeda S, Aoki T, Tomioka M, Shindo Y, Takishima T, Umeya K. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo. Biorheology. 1983;20(5):677-83. PubMed PMID: 6375756.
  • Singh D, Dixit VK, Saraf S, Saraf S. Formulation optimization of serratiopeptidase-loaded PLGA microspheres using selected variables. PDA J Pharm Sci Technol. 2009 Mar-Apr;63(2):103-12. PubMed PMID: 19634349.
  • Singh D, Singh MR. Development of antibiotic and debriding enzyme-loaded PLGA microspheres entrapped in PVA-gelatin hydrogel for complete wound management. Artif Cells Blood Substit Immobil Biotechnol. 2012 Oct;40(5):345-53. doi: 10.3109/10731199.2012.675337. Epub 2012 Apr 30. PubMed PMID: 22540900.
  • Singh KP, Chhabra G, Sharma V, Pathak K. Thermosensitive periodontal sol of ciprofloxacin hydrochloride and serratiopeptidase: Pharmaceutical and mechanical analysis. Int J Pharm Investig. 2014 Jan;4(1):5-14. doi: 10.4103/2230-973X.127734. PubMed PMID: 24678456; PubMed Central PMCID: PMC3944617.
  • Subathra DC, Alam S, Nag SK, Jemimah NS, Mohanasrinivasan V, Vaishnavi B. Studies on growth kinetics of Serratia marcescens VITSD2 and optimization of fermentation conditions for serratiopeptidase production. Antiinflamm Antiallergy Agents Med Chem. 2014;13(2):88-92. PubMed PMID: 25056366.
  • Suzuki K, Niho T, Yamada H, Yamaguchi K, Ohnishi H. [Experimental study of the effects of bromelain on the sputum consistency in rabbits]. Nihon Yakurigaku Zasshi. 1983 Mar;81(3):211-6. Japanese. PubMed PMID: 6862320.
  • Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Nakai Y. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica. 1984;3(8) 526-530. PMID: 6366808.
  • Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Nakai Y. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica. 1984;3(8):526-30. PubMed PMID: 6366808.
  • Tago. T. and Mitsui, S. Effects of Serrapeptase in dissolution of sputum, especially in patients with bronchial asthma. Jap. Clin. Exp. Med. 49:222-228, 1972.
  • Tanabe K, Tsuboi H, Maejima H, Arai S, Katsuoka K. Non-pigmented fixed drug eruption induced by eprazinone hydrochloride. Dermatol Online J. 2005;11(3) 25. PMID: 16409921.
  • Tanabe K, Tsuboi H, Maejima H, Arai S, Katsuoka K. Non-pigmented fixed drug eruption induced by eprazinone hydrochloride. Dermatol Online J. 2005 Dec 1;11(3):25. PubMed PMID: 16409921.
  • Tanimoto T, Fukuda H, Kawamura J. [On the quality of enzyme preparation (V). Serratiopeptidase preparation]. Eisei Shikenjo Hokoku. 1983;(101):92-5. Japanese. PubMed PMID: 6372920.
  • Tanimoto T, Fukuda H, Yamaha T. [Studies on the quality of enzyme preparations (VII)–serrapeptase preparation] Eisei Shikenjo Hokoku. 1986 38-45. PMID: 3552093.
  • Tanimoto T, Fukuda H, Yamaha T. [Studies on the quality of enzyme preparations (VII)–serrapeptase preparation]. Eisei Shikenjo Hokoku. 1986;(104):38-45. Japanese. PubMed PMID: 3552093.
  • Umashankar MS, Sachdeva RK, Gulati M. Aquasomes: a promising carrier for peptides and protein delivery. Nanomedicine. 2010 Jun;6(3):419-26. doi: 10.1016/j.nano.2009.11.002. Epub 2009 Nov 18. PubMed PMID: 19931422.
  • Venkatpurwar VP, Pokharkar VB. Biosynthesis of gold nanoparticles using therapeutic enzyme: in-vitro and in-vivo efficacy study. J Biomed Nanotechnol. 2010 Dec;6(6):667-74. PubMed PMID: 21361131.
  • Vicari E, La Vignera S, Battiato C, Arancio A. [Treatment with non-steroidal anti-inflammatory drugs in patients with amicrobial chronic prostato-vesiculitis: transrectal ultrasound and seminal findings]. Minerva Urol Nefrol. 2005 Mar;57(1):53-9. Italian. PubMed PMID: 15944522.
  • Viswanatha Swamy AH, Patil PA. Effect of some clinically used proteolytic enzymes on inflammation in rats. Indian J Pharm Sci. 2008 Jan;70(1):114-7. doi: 10.4103/0250-474X.40347. PubMed PMID: 20390096; PubMed Central PMCID: PMC2852049.
  • WebMD. “Are Anti-Inflammatory Pain Relievers Safe for You?”
  • Wirthlin MR, Wu R, Lai YT. Black yeast in dental unit waterlines. II. Remediation project report. J West Soc Periodontol Periodontal Abstr. 2014;62(4):99-105. PubMed PMID: 25707123.
  • Yamada S, Ogawa T, Nishimiya J, Yuasa T, Taketazu F. Masticator myopathy. Muscle Nerve. 2003 Jul;28(1):123-7. PubMed PMID: 12811784.
  • Yamazaki, J. et al. Anti-inflammatory activity of Serrapeptase, a protease produced by a strain of Serratia. Folia Pharmacol. Japon. 6^302-314,1967.
  • Yokota Y, Kagami A, Nagano A. [A case of Pulmonary infiltration with eosinophilia syndrome induced by serrapeptase]. Nihon Naika Gakkai Zasshi. 1992 Nov;81(11) 1865-1866. PMID: 1479230.
  • Yokota Y, Kagami A, Nagano A. [A case of Pulmonary infiltration with eosinophilia syndrome induced by serrapeptase]. Nihon Naika Gakkai Zasshi. 1992 Nov 10;81(11):1865-6. Japanese. PubMed PMID: 1479230.
  • Yoshida K. Sfericase, a novel proteolytic enzyme. Int J Clin Pharmacol Ther Toxicol. 1983 Sep;21(9):439-46. Review. PubMed PMID: 6354943.